Respiratory syncytial virus in young children: community cohort study integrating serological surveys, questionnaire and electronic health records, Born in Bradford cohort, England, 2008 to 2013
- PMID: 33573711
- PMCID: PMC7879500
- DOI: 10.2807/1560-7917.ES.2021.26.6.2000023
Respiratory syncytial virus in young children: community cohort study integrating serological surveys, questionnaire and electronic health records, Born in Bradford cohort, England, 2008 to 2013
Abstract
BackgroundBronchiolitis caused by respiratory syncytial virus (RSV) is a major cause of mortality and morbidity in infants.AimTo describe RSV epidemiology in children in the community in a high-income setting.MethodsWe used stored blood samples from the United Kingdom Born in Bradford cohort study that had been collected at birth, age 1 and 2 years old, tested for IgG RSV postfusion F antibody and linked to questionnaires and primary and hospital care records. We used finite mixture models to classify children as RSV infected/not infected according to their antibody concentrations at age 1 and 2 years. We assessed risk factors for primary RSV infection at each age using Poisson regression models.ResultsThe study cohort included 700 children with cord blood samples; 490 had additional blood samples taken at both ages 1 and 2 years old. Of these 490 children, 258 (53%; 95% confidence interval (CI): 48-57%) were first infected with RSV at age 1, 99 of whom (38%; 95% CI: 33-43%) had been in contact with healthcare during peak RSV season (November-January). Having older siblings, birth in October-June and attending formal childcare were associated with risk of RSV infection in infancy. By age 2, a further 164 of 490 children (33%; 95% CI: 29-38%) had been infected.ConclusionOver half of children experienced RSV infection in infancy, a further one third had evidence of primary RSV infection by age 2, and one in seven remained seronegative by their second birthday. These findings will inform future analyses to assess the cost-effectiveness of RSV vaccination programmes in high-income settings.
Keywords: RSV; child; infant; respiratory syncytial virus; respiratory viruses; serological survey.
Conflict of interest statement
Figures


Similar articles
-
The contribution of child, family and health service factors to respiratory syncytial virus (RSV) hospital admissions in the first 3 years of life: birth cohort study in Scotland, 2009 to 2015.Euro Surveill. 2019 Jan;24(1):1800046. doi: 10.2807/1560-7917.ES.2019.24.1.1800046. Euro Surveill. 2019. PMID: 30621817 Free PMC article.
-
Epidemiology of respiratory syncytial virus in a community birth cohort of infants in the first 2 years of life.Eur J Pediatr. 2021 Jul;180(7):2125-2135. doi: 10.1007/s00431-021-03998-0. Epub 2021 Feb 25. Eur J Pediatr. 2021. PMID: 33634335
-
Assessing the Burden of Laboratory-Confirmed Respiratory Syncytial Virus Infection in a Population Cohort of Australian Children Through Record Linkage.J Infect Dis. 2020 Jun 16;222(1):92-101. doi: 10.1093/infdis/jiaa058. J Infect Dis. 2020. PMID: 32031631
-
Burden of hospital admissions caused by respiratory syncytial virus (RSV) in infants in England: A data linkage modelling study.J Infect. 2019 Jun;78(6):468-475. doi: 10.1016/j.jinf.2019.02.012. Epub 2019 Feb 26. J Infect. 2019. PMID: 30817978
-
The epidemiology of respiratory syncytial virus (RSV) infections in South African children.S Afr Med J. 1999 Oct;89(10):1079-84. S Afr Med J. 1999. PMID: 10582064 Review.
Cited by
-
Single-cell profiling demonstrates the combined effect of wheeze phenotype and infant viral infection on airway epithelial development.Sci Adv. 2025 May 23;11(21):eadr9995. doi: 10.1126/sciadv.adr9995. Epub 2025 May 23. Sci Adv. 2025. PMID: 40408478 Free PMC article.
-
RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein.Viruses. 2022 Oct 29;14(11):2396. doi: 10.3390/v14112396. Viruses. 2022. PMID: 36366494 Free PMC article. Review.
-
Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands.Vaccines (Basel). 2023 Dec 2;11(12):1807. doi: 10.3390/vaccines11121807. Vaccines (Basel). 2023. PMID: 38140212 Free PMC article.
-
Respiratory Syncytial Virus Prevalence and Risk Factors among Healthy Term Infants, United States.Emerg Infect Dis. 2024 Oct;30(10):2199-2202. doi: 10.3201/eid3010.240609. Emerg Infect Dis. 2024. PMID: 39320243 Free PMC article.
-
How early life respiratory viral infections impact airway epithelial development and may lead to asthma.Front Pediatr. 2024 Aug 2;12:1441293. doi: 10.3389/fped.2024.1441293. eCollection 2024. Front Pediatr. 2024. PMID: 39156016 Free PMC article. Review.
References
-
- Shi T, McAllister DA, O’Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. RSV Global Epidemiology Network Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946-58. 10.1016/S0140-6736(17)30938-8 - DOI - PMC - PubMed
-
- NHS Digital. Hospital Admitted Patient Care Activity, 2017-18 - NHS Digital. England. 2018 [Accessed 12 Feb 2019]. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/hos...
-
- PATH Vaccine Resource Library. RSV Vaccine and mAb Snapshot. [Accessed 31 May 2019]. Available from: https://vaccineresources.org/details.php?i=1562
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical